Meeting
2019 Genitourinary Cancers Symposium
Fecal microbiota transplantation for TKI-induced diarrhea in patients with metastatic renal cell carcinoma.
Authors
Ernesto Rossi
Medical Oncology Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Ernesto Rossi , Gianluca Ianiro , Brigida Anna Maiorano , Roberto Iacovelli , Loris Lopetuso , Carlo Romano Settanni , Luca Masucci , Gianluca Quaranta , Maurizio Sanguinetti , Emilio Bria , Antonio Gasbarrini , Giampaolo Tortora , Giovanni Cammarota , Giovanni Schinzari
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 615)
DOI
10.1200/JCO.2019.37.7_suppl.615
Abstract #
615
Poster Bd #
G10
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Effects of pazopanib (PAZ) and sunitinib (SUN) dose modification on safety and efficacy in patients with metastatic renal cell carcinoma (mRCC) from COMPARZ.
First Author: Georg A. Bjarnason
Poster
2017 Genitourinary Cancers Symposium
A phase II study of alternative sunitinib scheduling in patients with metastatic renal cell carcinoma.
First Author: Eric Jonasch
Poster
2016 Genitourinary Cancers Symposium
Real world chart review of adverse event management in patients taking tyrosine kinase inhibitors (TKIs) for metastatic renal cell carcinoma (mRCC) by line of therapy (LoT).
First Author: Sandhya Srinivas
Poster
2015 ASCO Annual Meeting
Efficacy and safety of endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors (TKI) after programmed cell death 1 (PD-1) inhibitor treatment in patients with metastatic clear cell renal cell carcinoma (mccRCC).
First Author: Rosa Nadal